Pharmacological Reviews, 59(2), 151184
Discover how leading R&D teams use Cypris Q to monitor technology landscapes and identify opportunities faster - Book a demo Executive Summary GLP-1based obesity pharmacotherapy has evolved from single-hormone appetite suppression into a platform competition spanning poly-agonist biology, delivery convenience, and body-composition optimization
Advertencia: Producto de uso delicado que debe ser administrado bajo vigilancia mdica
Serotonin-Noradrenaline Reuptake Inhibitors (SNRIs): Originally used for depression, some SNRIs, like Phentermine/Topiramate (Qsymia), have been shown to promote satiety and reduce cravings, leading to weight loss
[10] Tertomotide Doti N, Mardirossian M, Sandomenico A, Ruvo M, Caporale A (August 2021)